Original Research
Accepted on 14 Aug 2025
Inhibition of the oncogenic channel Kv10.1 by the antipsychotic drug penfluridol
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655406
Type at least 3 characters
541 articles
Original Research
Accepted on 05 Aug 2025
CFTR Ion Transport Deficiency Primes the Epithelium for Partial Epithelial-Mesenchymal Transition in Cystic Fibrosis
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655479
- 484 views
Original Research
Published on 04 Aug 2025
Selective amino acid formulation enhances anion secretion and restores function in cystic fibrosis mutations
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522130
- 699 views
Review
Published on 29 Jul 2025
Factors that influence the Na/K-ATPase signaling and function
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1639859
- 652 views
Original Research
Accepted on 11 Jul 2025
The Interplay of Polarizable Water and Protein in the Activation of the M2 Channel
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532697
- 244 views
Review
Published on 04 Jun 2025
Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1580086
- 1,598 views
Original Research
Published on 21 May 2025
Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1568908
- 1,009 views
Review
Published on 09 May 2025
The role of transient receptor potential channels in chronic kidney disease-mineral and bone disorder
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583487
- 1,736 views
Review
Published on 30 Apr 2025
Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561956
- 2,260 views
Original Research
Published on 29 Apr 2025
Early reduction of skin potassium without sodium accumulation in the pathogenesis of salt sensitivity in primary aldosteronism
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575972
- 1,266 views
Original Research
Published on 22 Apr 2025
Gaussian white noise stimulation as an alternative method to excite sensory neurons
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561905
- 1,085 views
Original Research
Published on 10 Apr 2025
The venom of Cyriopagopus schmidti spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potential
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566312
- 1,442 views
Review
Published on 28 Mar 2025
Role of voltage-gated chloride channels in epilepsy: current insights and future directions
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1560392
- 1,540 views
Review
Published on 26 Mar 2025
Sodium channels as a new target for pain treatment
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573254
- 5,152 views
- 2 citations
Review
Published on 24 Mar 2025
Mechanisms mediating effects of cardiotonic steroids in mammalian blood cells
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520927
- 1,347 views
Opinion
Published on 21 Mar 2025
When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1535259
- 1,007 views